The quality of life index: a pilot study integrating treatment efficacy and quality of life in oncology

The majority of women diagnosed with breast cancer will experience some form of drug-related toxicity and subsequent impairments in Health-related Quality of Life (HRQoL). Despite this, HRQoL is assessed inconsistently and there is no validated method to integrate HRQoL data into the assessment of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, A., Philip, E. J., Dewitt, B., Hanmer, J., Chattopadhyay, A., Yau, C., Melisko, M. E., Esserman, L. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560724/
https://www.ncbi.nlm.nih.gov/pubmed/33083531
http://dx.doi.org/10.1038/s41523-020-00193-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560724/
https://www.ncbi.nlm.nih.gov/pubmed/33083531
http://dx.doi.org/10.1038/s41523-020-00193-6

Ejemplares similares